Dyspnoea and oxygen therapy in chronic obstructive pulmonary disease

References

• Rodriguez-Roisin R, Rabe K, Anzueto A, Bourbeau J, Calverley P, Casas A, et al.. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: global initiative for chronic obstructive lung disease; 2008 [accessed 2009 July 31].
   Google Scholar
• Celli B, MacNee B. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932–46.
   PubMed Web of Science ®Google Scholar
• British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52(Suppl 5):S1–28.
   Google Scholar
• McKenzie D, Abramson M, Crockett A, Glasgow N, Jenkins S, McDonald C, et al.. The COPD-X plan: Australian and New Zealand Guidelines for the management of chronic obstructive pulmonary disease. [updated 2009 April; accessed 2009 July 31]. Available from: http://www.copdx.org.au.
   Google Scholar
• National Institute for Clinical Excellence. National clinical guideline on management of chronic obstructive pulmonary disease in primary and secondary care. Thorax 2004;59(Suppl 1):1–232.
   Google Scholar
• Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977;1:1645–8.
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681–6.
   PubMed Web of Science ®Google Scholar
• Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391–8.
   PubMed Web of Science ®Google Scholar
• O’Donnell D, Webb K. Mechanisms of dyspnea in COPD. In: , Mahler D, O’Donnell D, editors. Dyspnea, mechanisms, measurement and management, 2nd edn. New York: Marcel Dekker; 2005. p. 29–58.
   Google Scholar
• O’Donnell D, Banzett R, Carrieri-Kohlman V, Casaburi R, Davenport P, Gandevia S, et al.. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007;4:145–68.
   PubMedGoogle Scholar
• Williams M, Garrard A, Cafarella P, Petkov J, Frith P. Quality of recalled dyspnoea is different from exercise-induced dyspnoea: an experimental study. Aust J Physiother 2009;55:177–83.
   PubMed Web of Science ®Google Scholar
• Hill K, Jenkins C, Hillman D, Eastwood P. Dyspnoea in COPD: can inspiratory muscle training help? Aust J Physiother 2004;50:169–80.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 1999;159:321–40.
   PubMed Web of Science ®Google Scholar
• O’Driscoll B. Short burst oxygen therapy in patients with COPD. Monaldi Arch Chest Dis 2008;69:70–4.
   PubMedGoogle Scholar
• Uronis H, Abernathy A. Oxygen for relief of dyspnea: what is the evidence? Curr Opin Support Palliat Care 2008;2:89–94.
   PubMedGoogle Scholar
• Calverley P, Walker P. Chronic obstructive pulmonary disease. Lancet 2003;362:1053–61.
   PubMed Web of Science ®Google Scholar
• Hogg J, Chu F, Utokaparch S, Woods R, Elliott W, Buzatu L, et al.. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645–53.
   PubMed Web of Science ®Google Scholar
• O’Donnell D, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD 2006;3:219–32.
   PubMedGoogle Scholar
• Rodarte J. Physiology of airflow limitation in emphysema. In: , Fessler H, Reilly J, Sugarbaker D, editors. Lung biology in health and disease Lung volume reduction surgery for emphysema. New York: Marcel Dekker; 2004. p. 43–64.
   Google Scholar
• Milic-Emili J. Respiratory mechanics. Monaldi Arch Chest Dis 1998;53:294–5.
   PubMedGoogle Scholar
• Cooper C. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006;119(10 Suppl 1):21–31.
   PubMedGoogle Scholar
• Miller J, Dempsey J. Pulmonary limitations to exercise performance: the effects of healthy aging and COPD. In: , Massaro D, editor. Lung development and regeneration. New York: Marcel Dekker; 2004. p. 525–71.
   Google Scholar
• Haverkamp H, Dempsey J, Miller J, Romer L, Eldridge M. Physiologic responses to exercise. In: , Hamid Q, Shannon J, Martin J, editors. The physiologic basis of respiratory disease. Hamilton: Decker Inc; 2005. p. 525–40.
   Google Scholar
• O’Donnell D, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006;15(100):61–7.
   Google Scholar
• Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.. ATS/ERS Task Force: standardisation of lung function testing. Standardisation of spirometry. Eur Respir J 2005;26:319–38.
   PubMed Web of Science ®Google Scholar
• Tantucci C, Pinelli V, Cossi S, Guerini M, Donato F, Grassi V, et al.. Reference values and repeatability of inspiratory capacity for men and women aged 65–85. Respir Med 2006;100:871–7.
   PubMed Web of Science ®Google Scholar
• O’Donnell D, Webb K. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993;148:1351–7.
   PubMed Web of Science ®Google Scholar
• Di Marco F, Milic-Emili J, Boveri B, Carlucci P, Santus P, Casanova F, et al.. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur Respir J 2003;21:86–94.
   PubMed Web of Science ®Google Scholar
• Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emili J, et al.. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000;16:269–75.
   PubMed Web of Science ®Google Scholar
• Newton M, O’Donnell D, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002;121(4):1042–50.
   PubMed Web of Science ®Google Scholar
• O’Donnell D, Revill S, Webb K. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(5):770–7.
   PubMed Web of Science ®Google Scholar
• Quanjer P, Tommelin G, Cotes J. Lung volumes and forced ventilatory flows. Report of the Working Party for Standardization of Lung Function Tests. Eur Respir J 1993;6(Suppl 16):5–40.
   PubMedGoogle Scholar
• O’Donnell D, Lam M, Webb K. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542–9.
   PubMed Web of Science ®Google Scholar
• O’Donnell D. Is sustained pharmacologic lung volume reduction now possible in COPD? Chest 2006;129(3):501–3.
   PubMed Web of Science ®Google Scholar
• Parker C, Voduc N, Aaron S, Webb K, O’Donnell D. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 2005;26:420–8.
   PubMed Web of Science ®Google Scholar
• Roussos C, Macklem P. The respiratory muscles. New Engl J Med 1982;307:786–97.
   PubMed Web of Science ®Google Scholar
• Campbell E, Howell J. The sensation of breathlessness. Br Med Bull 1963;19:36–40.
   PubMed Web of Science ®Google Scholar
• O’Donnell D, Webb KExercise In:, Calverley P, et al.., editors. Chronic obstructive pulmonary disease, 2nd edn. London: Edward Arnold Publishers; 2003. p. 243–69.
   Google Scholar
• Pride N, Macklem P. The respiratory system. In: , Macklem P, Mead J, editors. Handbook of physiology Section 3. Bethesda, MD: American Physiological Society; 1986. p. 659–92.
   Google Scholar
• Pepe P, Marini J. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis 1982;126:166–70.
   PubMed Web of Science ®Google Scholar
• Tantucci C, Duguet A, Similowski T, Zelter M, Derenne J-P, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998;12:799–804.
   PubMed Web of Science ®Google Scholar
• Aliverti A, Macklem P. Point:Counterpoint: the major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles. J Appl Physiol 2008;105:749–57.
   PubMed Web of Science ®Google Scholar
• Loring S, Garcia-Jacques M, Malhotra A. Pulmonary characteristics in COPD and mechanisms of increased work of breathing. J Appl Phys 2009;107:309–14.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R, Drakulovic M, Rodriguez D, Roca J, Barbera J, Wagner P. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease. J Appl Physiol 2009;106:1902–8.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society/European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive puomonary disease. Am J Respir Crit Care Med 1999;159:S1–40.
   PubMedGoogle Scholar
• Maltais F, Simard A-A, Simard C, Jobin J, Desgagnes P, Le Blanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996;153:288–93.
   PubMed Web of Science ®Google Scholar
• O’Brien K, Geddes E, Reid W, Brooks D, Crowe J. Inspiratory muscle training compared with other rehabilitation interventions in chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2008;28:128–41.
   PubMed Web of Science ®Google Scholar
• Borg G. Psychosocial bases of perceived exertion. Med Sci Sports Exer 1982;14:377–81.
   PubMed Web of Science ®Google Scholar
• Medical Research Council. Standardized questionnaire of respiratory symptoms. Br Med J 1960;2:1665.
   PubMedGoogle Scholar
• Mahler D, Weinberg D, Wells C, Feinstein A. The measurement of dyspnoea. Contents, interobserver agreement, and physiologic correlates of two new clinical indices. Chest 1984;85:751–8.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42(10):773–8.
   PubMed Web of Science ®Google Scholar
• Jones P, Quirk F, Baveystock C, Littlejohns P. A self-complete measure of healthstatus for chronic airflow obstruction. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321–7.
   PubMed Web of Science ®Google Scholar
• Clini E, Ambrosino N. Nonpharmacological treatment and relief of symptoms in COPD. Eur Respir J 2008;32:218–28.
   PubMed Web of Science ®Google Scholar
• Hill K, Jenkins S, Philippe D, Cecins N, Shepherd K, Green D, et al.. High-intensity inspiratory muscle training in COPD. Eur Respir J 2006;27:1119–28.
   PubMed Web of Science ®Google Scholar
• Croxton T, Bailey W. Long-term oxygen treatment in COPD: recommendations for future research. Am J Respir Crit Care Med 2006;174:373–8.
   PubMed Web of Science ®Google Scholar
• American Association for Respiratory Care. AARC clinical practice guideline: oxygen therapy in the home or alternative site health care facility. Respir Care 2007;52:1063–8.
   PubMed Web of Science ®Google Scholar
• McDonald C, Crockett A, Young I. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med J Aust 2005;182:621–6.
   PubMed Web of Science ®Google Scholar
• Ontario Ministry of Health and Long Term Care Assistive Devices Program. Home Oxygen Program (HOP) Administration Manual. 2005 [accessed 2009 February 16].
   Google Scholar
• Royal College of Physicians. Domiciliary oxygen services. Clinical guidelines and advice for prescribers. A report of the Royal College of Physicians, 1999.
   Google Scholar
• Cain S. Gas exchange in hypoxia, apnea, and hyperoxia. In: , Fishman A, Farhi L, Tenney S, editors. Handbook of physiology Section 3: the respiratory system. Bethesda, MD: American Physiology Society; 1987. p. 403–20.
   Google Scholar
• Bradley J, O’Neill B. Short-term ambulatory oxygen for chronic obstructive pulmonary disease (Review). Cochrane Database Syst Rev 2005;(4): No. CD004356.
   Web of Science ®Google Scholar
• Albert P, Calverley P. Drugs (including oxygen) in severe COPD. Eur Respir J 2008;31:1114–24.
   PubMed Web of Science ®Google Scholar
• Snider G. Enhancement of exercise performance in COPD patients by hyperoxia. Chest 2002;122:1830–6.
   PubMed Web of Science ®Google Scholar
• Somfay A, Porszasz J, Lee S, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001;18:77–84.
   PubMed Web of Science ®Google Scholar
• Calverley P. Dynamic hyperinflation. Is it worth measuring? Proc Am Thorac Soc 2006;3:239–44.
   PubMedGoogle Scholar
• Peters M, Webb K, O’Donnell D. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax 2006;61:559–67.
   PubMed Web of Science ®Google Scholar
• Somfay A, Porszasz J, Lee S, Casaburi R. Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. Chest 2002;121:393–400.
   PubMed Web of Science ®Google Scholar
• Young P. Ambulatory and training oxygen: a review of the evidence and guidelines for prescription. NZ J Physiother 2005;33:7–12.
   Google Scholar
• Nonoyama M, Brooks D, Lacasse Y, Guyatt G, Goldstein R. Oxygen therapy during exercise training in chronic obstructive pulmonary disease (Review). Cochrane Database Syst Rev 2007;(2): No. CD005372.
   PubMed Web of Science ®Google Scholar
• Emtner M, Porszasz J, Burns M, Somfray A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003;168:1034–42.
   PubMed Web of Science ®Google Scholar
• Cukier A, Ferreira C, Stelmach R, Ribeiro M, Cortopassi F, Calverley P. The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD. Respir Med 2007;101:746–53.
   PubMed Web of Science ®Google Scholar
• Ambrosino N, Strambi S. New strategies to improve exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J 2004;24:313–22.
   PubMed Web of Science ®Google Scholar
• O’Donnell D, Bain D, Webb K. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 1997;155:530–5.
   PubMed Web of Science ®Google Scholar
• O’Donnell D, D’Arsigny C, Webb K. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:892–8.
   PubMed Web of Science ®Google Scholar
• Moore R, Berlowitz D, Pretto J, Brazzale D, Denehy L, Jackson B, et al.. Acute effects of hyperoxia on resting pattern of ventilation and dyspnoea in COPD. Respirology 2009;14:545–50.
   PubMed Web of Science ®Google Scholar
• Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in ‘pink puffers’. Lancet 1981;1:907–9.
   PubMed Web of Science ®Google Scholar
• O’Neill B, MacMahon J, Bradley J. Short-burst oxygen therapy in chronic obstructive pulmonary disease. Respir Med 2006;100:1129–38.
   PubMed Web of Science ®Google Scholar
• Eaton T, Fergusson G, Kolbe J, Lewis C, West T. Short-burst oxygen for COPD patients: a 6-month randomised, controlled study. Eur Respir J 2006;697–704.
   PubMed Web of Science ®Google Scholar
• Abernathy A, McDonald C, Frith P, Clark K, Herndon J, Marcello J, et al.. Palliative oxygen versus medical air for relief of dyspnea: results of an international, multi-site randomised controlled trial. Respirology 2009;14:A29.
   Google Scholar
• Liss H, Grant B. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988;137:1285–8.
   PubMed Web of Science ®Google Scholar
• Schwartzstein R, Lahive K, Pope A, Weinberger S, Weiss J. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987;136:58–61.
   PubMed Web of Science ®Google Scholar
• Spence D, Graham D, Ahmed J, Rees K, Pearson M, Calverley P. Does cold air affect exercise capacity and dyspnea in stable chronic obstructive pulmonary disease? Chest 1993;103:693–6.
   PubMed Web of Science ®Google Scholar
• Mckinlay L, Pulakal S, Turkington P, O’Driscoll B. Short burst oxygen therapy does not relieve breathlessness after exercise in patients with severe COPD who are not hypoxaemic at rest. Thorax 2007;62(Suppl iii):A67.
   Google Scholar
• Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 2005;25:1032–8.
   PubMed Web of Science ®Google Scholar
• Lilker E, Karnick A, Lerner L. Portable oxygen in chronic obstructive lung disease with hypoxemia and cor pulmonale: a controlled double-blind crossover study. Chest 1975;68(2):236–41.
   PubMed Web of Science ®Google Scholar
• Sandland C, Morgan M, Singh S. Patterns of domestic activity and ambulatory oxygen usage in COPD. Chest 2008;134:753–60.
   PubMed Web of Science ®Google Scholar
• Eaton T, Garrett J, Young P, Fergusson W, Kolbe J, Rudkin S, et al.. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 2002;20(2):306–12.
   PubMed Web of Science ®Google Scholar
• McDonald C, Blyth C, Lazarus M, Marschner I, Barter C. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med 1995;152:1616–9.
   PubMed Web of Science ®Google Scholar
• Nonoyama M, Brooks D, Guyatt G, Goldstein R. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007;176:343–9.
   PubMed Web of Science ®Google Scholar
• Moore R, Berlowitz D, Denehy L, Pretto J, Brazzale D, Sharpe K, et al.. Domiciliary ambulatory oxygen is not beneficial in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax 2011;66:32–37.
   PubMed Web of Science ®Google Scholar
• Ram F, Wedzicha J. Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2003;(1): No. CD000238.
   Web of Science ®Google Scholar
• Cranston J, Crockett A, Moss J, Alpers J. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;(4): No. CD001744.
   PubMed Web of Science ®Google Scholar
• Austin M, Wood-Baker R. Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;(3): No. CD005534.
   PubMed Web of Science ®Google Scholar